Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GH-21 by HUYA Bioscience International for Solid Tumor: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Solid Tumor. According to GlobalData,...
Data Insights
GH-21 by HUYA Bioscience International for Non-Small Cell Lung Cancer: Likelihood of Approval
GH-21 is under clinical development by HUYA Bioscience International and currently in Phase I for Non-Small Cell Lung Cancer. According...